AAAAAA
Results: 1-25/46
Authors:
FERRAJOLI A
TALPAZ M
KURZROCK R
HARRIS D
VAN Q
ESTEY EH
ESTROV Z
Citation: A. Ferrajoli et al., THROMBOPOIETIN STIMULATES MYELODYSPLASTIC SYNDROME GRANULOCYTE-MACROPHAGE AND ERYTHROID PROGENITOR PROLIFERATION, Leukemia & lymphoma, 30(3-4), 1998, pp. 279-292
Authors:
ESTEY EH
Citation: Eh. Estey, NEW AGENTS FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - FOCUS ONTOPOTECAN AND RETINOIDS, Leukemia, 12, 1998, pp. 13-15
Authors:
ESTEY EH
Citation: Eh. Estey, PROGNOSIS AND THERAPY OF SECONDARY MYELODYSPLASTIC SYNDROMES, Haematologica, 83(6), 1998, pp. 543-549
Authors:
ESTROV Z
THALL PF
TALPAZ M
ESTEY EH
KANTARJIAN HM
ANDREEFF M
HARRIS D
VAN Q
WALTERSCHEID M
KORNBLAU SM
Citation: Z. Estrov et al., CASPASE-2 AND CASPASE-3 PROTEIN-LEVELS AS PREDICTORS OF SURVIVAL IN ACUTE MYELOGENOUS LEUKEMIA, Blood, 92(9), 1998, pp. 3090-3097
Authors:
MUNKER R
KANTARJIAN H
OBRIEN S
KEATING M
ANDREEFF M
ESTEY EH
Citation: R. Munker et al., PHASE-I STUDY OF TAXOL IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIAS USING A WEEKLY SCHEDULE, Acta haematologica, 99(2), 1998, pp. 106-108
Authors:
ESTEY EH
Citation: Eh. Estey, TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - REPLY, Journal of clinical oncology, 15(4), 1997, pp. 1710-1711
Authors:
PELEG S
QIU HY
REDDY S
HARRIS D
VAN Q
ESTEY EH
TALPAZ M
ESTROV Z
Citation: S. Peleg et al., 1,25-DIHYDROXYVITAMIN D-3 AND ITS ANALOGS INHIBIT ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION BY SUPPRESSING INTERLEUKIN-1-BETA PRODUCTION, The Journal of clinical investigation, 100(7), 1997, pp. 1716-1724
Authors:
GHADDAR HM
PIERCE S
KANTARJIAN HM
FREIREICH EJ
KEATING MJ
ESTEY EH
Citation: Hm. Ghaddar et al., AMSACRINE AND CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE AS INDUCTION THERAPY FOR PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA, Leukemia & lymphoma, 22(1-2), 1996, pp. 71-76
Authors:
ESCUDIER SM
KANTARJIAN HM
ESTEY EH
Citation: Sm. Escudier et al., THROMBOSIS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA TREATED WITHAND WITHOUT ALL-TRANS-RETINOIC ACID, Leukemia & lymphoma, 20(5-6), 1996, pp. 435-439
Authors:
ANDERLINI P
GHADDAR HM
SMITH TL
PIERCE S
KANTARJIAN HM
OBRIEN S
KEATING MJ
FREIREICH EJ
ESTEY EH
Citation: P. Anderlini et al., FACTORS PREDICTING COMPLETE REMISSION AND SUBSEQUENT DISEASE-FREE SURVIVAL AFTER A 2ND COURSE OF INDUCTION THERAPY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RESISTANT TO THE FIRST, Leukemia, 10(6), 1996, pp. 964-969
Authors:
ANDERLINI P
LUNA M
KANTARJIAN HM
OBRIEN S
PIERCE S
KEATING MJ
ESTEY EH
Citation: P. Anderlini et al., CAUSES OF INITIAL REMISSION INDUCTION FAILURE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROMES, Leukemia, 10(4), 1996, pp. 600-608
Authors:
KANTARJIAN HM
BERAN M
OBRIEN S
ROBERTSON L
SIDDIK Z
YOSHIDA M
YANG LY
RIOS MB
KEATING MJ
MEYER M
KOWAL C
ESTEY EH
Citation: Hm. Kantarjian et al., EVALUATION OF CL-973, A PLATINUM ANALOG, IN REFRACTORY OR RELAPSED ACUTE-LEUKEMIA, Leukemia, 10(3), 1996, pp. 396-401
Authors:
WILHELM M
KANTARJIAN HM
OBRIEN S
PIERCE S
KEATING MJ
FREIREICH EJ
ESTEY EH
Citation: M. Wilhelm et al., PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS, Leukemia, 10(12), 1996, pp. 1870-1873
Authors:
GALE RP
HOROWITZ MM
REES JKH
GRAY RG
OKEN MM
ESTEY EH
KIM KM
ZHANG MJ
ASH RC
ATKINSON K
CHAMPLIN RE
DICKE KA
GAJEWSKI JL
GOLDMAN JM
HELBIG W
HENSLEEDOWNEY PJ
HINTERBERGER W
JACOBSEN N
KEATING A
KLEIN JP
MARMONT AM
PRENTICE HG
REIFFERS J
RIMM AA
ROWLINGS PA
SOBOCINSKI KA
SPECK B
WINGARD JR
BORTIN MM
Citation: Rp. Gale et al., CHEMOTHERAPY VERSUS TRANSPLANTS FOR ACUTE MYELOGENOUS LEUKEMIA IN 2NDREMISSION, Leukemia, 10(1), 1996, pp. 13-19
Authors:
POLLICARDO N
OBRIEN S
ESTEY EH
ALBITAR M
PIERCE S
KEATING M
KANTARJIAN HM
Citation: N. Pollicardo et al., SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA - CHARACTERISTICS AND PROGNOSIS OF 14 PATIENTS FROM A SINGLE INSTITUTION, Leukemia, 10(1), 1996, pp. 27-31
Authors:
KANTARJIAN HM
ESTEY EH
KEATING MA
Citation: Hm. Kantarjian et al., NEW CHEMOTHERAPEUTIC-AGENTS IN ACUTE MYELOID-LEUKEMIA, Leukemia, 10, 1996, pp. 4-6
Authors:
THALL PF
SIMON RM
ESTEY EH
Citation: Pf. Thall et al., NEW STATISTICAL STRATEGY FOR MONITORING SAFETY AND EFFICACY IN SINGLE-ARM CLINICAL-TRIALS, Journal of clinical oncology, 14(1), 1996, pp. 296-303
Authors:
WILHELM M
KANTARJIAN HM
OBRIEN S
PIERCE S
KEATING MJ
FREIREICH EJ
ESTEY EH
Citation: M. Wilhelm et al., PNEUMONIA DURING REMISSION INDUCTION CHEMOTHERAPY IN PATIENTS WITH AML OR MDS, Blood, 88(10), 1996, pp. 3411-3411
Authors:
ESTEY EH
KANTARJIAN HM
OBRIEN S
KORNBLAU S
ANDREEFF M
BERAN M
PIERCE S
KEATING M
Citation: Eh. Estey et al., HIGH REMISSION RATE, SHORT REMISSION DURATION IN PATIENTS WITH REFRACTORY-ANEMIA WITH EXCESS BLASTS (RAEB) IN TRANSFORMATION (RAEB-T) GIVENACUTE MYELOGENOUS LEUKEMIA (AML)-TYPE CHEMOTHERAPY IN COMBINATION WITH GRANULOCYTE-CSF (G-CSF), Cytokines and molecular therapy, 1(1), 1995, pp. 21-28
Authors:
SEYMOUR JF
ESTEY EH
Citation: Jf. Seymour et Eh. Estey, THE CONTRIBUTION OF AUER RODS TO THE CLASSIFICATION AND PROGNOSIS OF MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 17(1-2), 1995, pp. 79-85
Authors:
GHADDAR HM
PIERCE S
REED P
ESTEY EH
Citation: Hm. Ghaddar et al., PROGNOSTIC VALUE OF RESIDUAL NORMAL METAPHASES IN ACUTE MYELOGENOUS LEUKEMIA PATIENTS PRESENTING WITH ABNORMAL KARYOTYPE, Leukemia, 9(5), 1995, pp. 779-782
Authors:
SEYMOUR JF
ESTEY EH
KEATING MJ
KURZROCK R
Citation: Jf. Seymour et al., RESPONSE TO INTERFERON-ALPHA IN PATIENTS WITH HAIRY-CELL LEUKEMIA RELAPSING AFTER TREATMENT WITH 2-CHLORODEOXYADENOSINE, Leukemia, 9(5), 1995, pp. 929-932
Authors:
ANDERLINI P
BENJAMIN RS
WONG FC
KANTARJIAN HM
ANDREEFF M
KORNBLAU SM
OBRIEN S
MACKAY B
EWER MS
PIERCE SA
ESTEY EH
Citation: P. Anderlini et al., IDARUBICIN CARDIOTOXICITY - A RETROSPECTIVE STUDY IN ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASIA, Journal of clinical oncology, 13(11), 1995, pp. 2827-2834
Authors:
ESTROV Z
TALPAZ M
ESTEY EH
STRASSMANN G
Citation: Z. Estrov et al., ROLE OF SURAMIN AS AN IL-1 INHIBITOR IN SUPPRESSION OF ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION, Experimental hematology, 23(10), 1995, pp. 1080-1087
Authors:
THALL PF
SIMON RM
ESTEY EH
Citation: Pf. Thall et al., BAYESIAN SEQUENTIAL MONITORING DESIGNS FOR SINGLE-ARM CLINICAL-TRIALSWITH MULTIPLE OUTCOMES, Statistics in medicine, 14(4), 1995, pp. 357-379